SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Varian Associates (VAR)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: JakeStraw7/25/2006 10:20:25 AM
   of 203
 
Varian Medical Systems to Exhibit the Company's Industry-Leading System for Planning Radiotherapy Treatments
biz.yahoo.com
Monday July 24, 8:00 am ET

Eclipse(TM) software system speeds up treatment planning and expedites clinical adoption of the most modern cancer treatment techniques

PALO ALTO, Calif., July 24 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR), the world leader in cancer therapy technology, will exhibit the company's industry-leading Eclipse(TM) radiotherapy treatment planning system at the 48th annual meeting of The American Association of Physicists in Medicine (AAPM) taking place in Orlando, Florida from July 30 to August 3. Varian will also sponsor two special events in connection with the meeting.

Eclipse is the market's most comprehensive and versatile treatment planning program, capable of producing plans for conventional radiotherapy, intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), brachytherapy, and proton radiotherapy. The system incorporates numerous time-saving features like disease-specific planning protocols and easy-to-use optimization tools that make it easier and faster to plan sophisticated cancer treatments.

"With Eclipse, we've given clinics the capabilities they need to offer advanced treatments including IGRT, in addition to supporting the full range of more conventional treatments," says Dow Wilson, president of Varian's Oncology Systems business.

Ron Lalonde, PhD, chief scientific officer for D3 Advanced Radiation Planning Services in Pittsburgh, Pennsylvania, uses multiple treatment planning systems to produce IMRT plans for clinical customers around the country. He says: "Dose calculation with Eclipse is twice as fast" as other programs he uses. "Because 99 percent of our plans are for IMRT, we do things that are fairly dose calculation intensive. There is no question that the fluence optimization process with Eclipse has improved our IMRT planning. Because it's interactive, you can tweak the plans on the fly and generate better plans more rapidly."

Features that Expedite Planning

Eclipse incorporates a set of tools that streamline the process of creating a personalized plan for each patient, including: a customizable library of clinical protocols and treatment plan templates, remote planning capabilities, a tool for specifying normal tissue dose constraints, an interactive dose visualization display, and an automated segmentation tool that automates the contouring step in which doctors separate diseased tissues from surrounding healthy organs on 3-D diagnostic images.

"Eclipse's contouring tools help smooth the process," says Jerry Soen, director of medical physics at the Northern Illinois Medical Center.

Varian-Sponsored Events at AAPM

In addition to its exhibit on the trade show floor, Varian Medical Systems will sponsor the following two special events:

-- Saturday, July 29, 7:00 am - 5:00 pm: Users meeting for the Eclipse
treatment planning system and the On-Board Imager® device for
image-guided radiotherapy (IGRT), an all-day event where technology
users can share successes, discover best practices, learn from expert
colleagues and increase their expertise
(http://www.varian.com/AAPMusersmeeting).

-- Sunday, July 30, 6:30 - 9:30 pm: Symposium entitled: "Multi-Dimensional
Dose Conformality," on how imaging is transforming the practice of
radiation therapy (http://www.varian.com/symposium) .
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext